Industry sponsor intelligence
Lead-sponsor view of Jiangsu HengRui Medicine Co., Ltd.'s indexed peptide studies, development phases, active programs, completed work and recent registry changes.
Pipeline overview
Velocity
Study start year · indexed snapshot
Development
| Product | Studies | Early / I | Phase II | Phase III | Phase IV | Active |
|---|---|---|---|---|---|---|
| Ganirelix → | 1 | 0 | 0 | 1 | 0 | 0 |
| Goserelin → | 1 | 0 | 0 | 1 | 0 | 0 |
| Octreotide → | 1 | 0 | 0 | 1 | 0 | 1 |
Active peptide trials
Jiangsu HengRui Medicine Co., Ltd. · Advanced Gastroenteropancreatic Neuroendocrine Tumor
Phase 3
Recruiting
220
2026-05
Completed trials
Jiangsu HengRui Medicine Co., Ltd. · Infertile Female Subjects Undergoing Controlled Ovarian Hyperstimulation to Suppress Premature LH Surge and Prevent Early Ovulation
Phase 3
Completed
317
2025-09
Search sponsor records
This page groups studies where Jiangsu HengRui Medicine Co., Ltd. is listed as the lead industry sponsor. Collaborator-only records are not included in the count.
3 matching studies
Last registry update first
Recent updates